ZA200606547B - Benzoxazine for treating respiratory tract diseases - Google Patents

Benzoxazine for treating respiratory tract diseases

Info

Publication number
ZA200606547B
ZA200606547B ZA200606547A ZA200606547A ZA200606547B ZA 200606547 B ZA200606547 B ZA 200606547B ZA 200606547 A ZA200606547 A ZA 200606547A ZA 200606547 A ZA200606547 A ZA 200606547A ZA 200606547 B ZA200606547 B ZA 200606547B
Authority
ZA
South Africa
Prior art keywords
benzoxazine
respiratory tract
treating respiratory
tract diseases
diseases
Prior art date
Application number
ZA200606547A
Inventor
Bouyssou Thierry
Pestel Sabine
Hoenke Christoph
Rudolf Klaus
Buettner Frank
Schollenberger Hermann
Konetzki Ingo
Schnapp Andreas
Lustenberger Philipp
Schromm Kurt
Heine Claudia
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200606547B publication Critical patent/ZA200606547B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200606547A 2004-04-22 2006-08-07 Benzoxazine for treating respiratory tract diseases ZA200606547B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (en) 2004-04-22 2004-04-22 New drugs for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
ZA200606547B true ZA200606547B (en) 2008-04-30

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606547A ZA200606547B (en) 2004-04-22 2006-08-07 Benzoxazine for treating respiratory tract diseases

Country Status (20)

Country Link
EP (1) EP1765355B1 (en)
JP (1) JP2007533684A (en)
KR (2) KR101338947B1 (en)
CN (1) CN1946406A (en)
AU (1) AU2005235420C1 (en)
BR (1) BRPI0510084A (en)
CA (1) CA2559700C (en)
DE (1) DE102004019539A1 (en)
DK (1) DK1765355T3 (en)
EA (1) EA012045B1 (en)
EC (1) ECSP066948A (en)
ES (1) ES2403184T3 (en)
IL (1) IL177663A (en)
NO (1) NO20065061L (en)
NZ (1) NZ551272A (en)
PL (1) PL1765355T3 (en)
SG (1) SG152233A1 (en)
UA (1) UA85707C2 (en)
WO (1) WO2005102350A1 (en)
ZA (1) ZA200606547B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for the inhalation of beta agonists
JP5270343B2 (en) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Beta mimetic manufacturing method
BRPI0618370A2 (en) * 2005-11-09 2011-08-30 Boehringer Ingelheim Int aerosol drug formulation, drug use and inhalation kit
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
PL2231642T3 (en) 2008-01-11 2014-04-30 Novartis Ag Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
CA2828219A1 (en) 2011-02-25 2012-08-30 Irm Llc Pyrazolo [1,5-a] pyridines as trk inhibitors
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
WO2018108669A1 (en) 2016-12-12 2018-06-21 Boehringer Ingelheim International Gmbh Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
BR0110331A (en) * 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Beta-mimicking substances that have long-lasting activity, processes for preparing them and their use as medicines
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration

Also Published As

Publication number Publication date
AU2005235420C1 (en) 2011-02-24
EP1765355A1 (en) 2007-03-28
IL177663A0 (en) 2006-12-31
KR20130042662A (en) 2013-04-26
EA200601837A1 (en) 2007-04-27
KR20070054599A (en) 2007-05-29
CA2559700C (en) 2013-06-11
SG152233A1 (en) 2009-05-29
ES2403184T3 (en) 2013-05-16
PL1765355T3 (en) 2013-08-30
NO20065061L (en) 2006-11-07
NZ551272A (en) 2010-10-29
DK1765355T3 (en) 2013-04-08
CN1946406A (en) 2007-04-11
AU2005235420B2 (en) 2010-10-28
DE102004019539A1 (en) 2005-11-10
JP2007533684A (en) 2007-11-22
UA85707C2 (en) 2009-02-25
ECSP066948A (en) 2006-12-20
WO2005102350A1 (en) 2005-11-03
EP1765355B1 (en) 2013-03-06
AU2005235420A1 (en) 2005-11-03
KR101338947B1 (en) 2013-12-10
BRPI0510084A (en) 2007-10-16
EA012045B1 (en) 2009-08-28
IL177663A (en) 2014-04-30
CA2559700A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
ZA200606547B (en) Benzoxazine for treating respiratory tract diseases
HUS1500058I1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
PL1817282T3 (en) Phenoxyacetic acid derivatives useful for treating respiratory diseases
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0709512D0 (en) Disposable inhaler
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
EP1742641A4 (en) Methods and compositions for detecting and treating retinal diseases
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL178815A0 (en) The treatment of respiratory disease
EP1962869A4 (en) Treatment of respiratory diseases
GB0620840D0 (en) Medicaments for treating chronic respiratory disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
EP1755635A4 (en) Treatment of inflammatory airway disease
IL197125A0 (en) Drug combinations for treating airway diseases
EP1731171A4 (en) Preventive/remedy for respiratory diseases
GB0701456D0 (en) Treatment for respiratory disease
GB0403370D0 (en) Device for preventing retinal diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0520152D0 (en) Treatment of respiratory disease
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
ZA200804944B (en) Use of a disinfectant for treating respiratory tract infections
AU303175S (en) Elbow for respiratory mask